POLYBIOCEPT AB has a total of 19 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are POLYBIOCEPT GMBH, FULLHOPE BIOMEDICAL CO LTD and CELL CURE NEUROSCIENCES LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Canada | 2 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Republic of Korea | 2 | |
#6 | Brazil | 1 | |
#7 | Israel | 1 | |
#8 | Mexico | 1 | |
#9 | Russian Federation | 1 | |
#10 | Singapore | 1 | |
#11 | United States | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Maeurer Markus | 14 |
#2 | Dodoo Ernest | 8 |
#3 | Geyer Jakob | 7 |
#4 | Markus Maeurer | 3 |
#5 | Mäurer Markus | 1 |
Publication | Filing date | Title |
---|---|---|
EP3202784A1 | T-cell receptor sequences for active immunotherapy | |
MX2016016251A | Expansion of lymphocytes with a cytokine composition for active cellular immunotherapy. | |
WO2015189301A1 | Culture medium for cellular immunotherapy |